Bernard Gjata

1.4k total citations
26 papers, 694 citations indexed

About

Bernard Gjata is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Bernard Gjata has authored 26 papers receiving a total of 694 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Genetics and 9 papers in Oncology. Recurrent topics in Bernard Gjata's work include Virus-based gene therapy research (13 papers), CAR-T cell therapy research (9 papers) and Muscle Physiology and Disorders (8 papers). Bernard Gjata is often cited by papers focused on Virus-based gene therapy research (13 papers), CAR-T cell therapy research (9 papers) and Muscle Physiology and Disorders (8 papers). Bernard Gjata collaborates with scholars based in France, United States and United Kingdom. Bernard Gjata's co-authors include Olivier Danos, Adélaïda Sarukhan, Harald von Boehmer, Karin Jooss, Alain Sébille, Laetitia van Wittenberghe, Alban Vignaud, Séverine Charles, Fanny Collaud and Jean‐Pascal Lefaucheur and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Journal of Virology.

In The Last Decade

Bernard Gjata

25 papers receiving 686 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bernard Gjata France 15 375 330 153 141 93 26 694
Niek P. van Til Netherlands 18 476 1.3× 352 1.1× 172 1.1× 105 0.7× 152 1.6× 44 879
Séverine Charles France 13 458 1.2× 468 1.4× 142 0.9× 107 0.8× 85 0.9× 20 814
Gabriella Cotugno Italy 17 383 1.0× 316 1.0× 184 1.2× 161 1.1× 152 1.6× 37 792
Sergia Bortolanza Spain 11 547 1.5× 253 0.8× 153 1.0× 63 0.4× 113 1.2× 12 725
Gijsbert P. van Nierop Netherlands 15 260 0.7× 117 0.4× 118 0.8× 154 1.1× 125 1.3× 28 779
Colin L. Sweeney United States 15 752 2.0× 286 0.9× 207 1.4× 315 2.2× 103 1.1× 31 1.1k
Yoji Ogasawara Japan 12 428 1.1× 214 0.6× 116 0.8× 152 1.1× 29 0.3× 47 817
Grant J. Logan Australia 15 529 1.4× 308 0.9× 78 0.5× 120 0.9× 43 0.5× 37 767
Rosa Romano Italy 12 768 2.0× 331 1.0× 161 1.1× 141 1.0× 37 0.4× 23 1.0k
Yutaka Negishi Japan 16 233 0.6× 199 0.6× 66 0.4× 71 0.5× 70 0.8× 37 576

Countries citing papers authored by Bernard Gjata

Since Specialization
Citations

This map shows the geographic impact of Bernard Gjata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Gjata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Gjata more than expected).

Fields of papers citing papers by Bernard Gjata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard Gjata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Gjata. The network helps show where Bernard Gjata may publish in the future.

Co-authorship network of co-authors of Bernard Gjata

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard Gjata. A scholar is included among the top collaborators of Bernard Gjata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard Gjata. Bernard Gjata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Colella, Pasqualina, Manuel J. Gómez, Maria Grazia Biferi, et al.. (2020). Gene therapy with secreted acid alpha-glucosidase rescues Pompe disease in a novel mouse model with early-onset spinal cord and respiratory defects. EBioMedicine. 61. 103052–103052. 18 indexed citations
2.
Cagin, Umut, Francesco Puzzo, Manuel J. Gómez, et al.. (2020). Rescue of Advanced Pompe Disease in Mice with Hepatic Expression of Secretable Acid α-Glucosidase. Molecular Therapy. 28(9). 2056–2072. 20 indexed citations
3.
Rocha, Sylvie Da, Jérémy Bigot, Fanny Onodi, et al.. (2019). Temporary Reduction of Membrane CD4 with the Antioxidant MnTBAP Is Sufficient to Prevent Immune Responses Induced by Gene Transfer. Molecular Therapy — Methods & Clinical Development. 14. 285–299. 9 indexed citations
4.
Israeli, David, Jérémie Cosette, Guillaume Corre, et al.. (2019). An AAV-SGCG Dose-Response Study in a γ-Sarcoglycanopathy Mouse Model in the Context of Mechanical Stress. Molecular Therapy — Methods & Clinical Development. 13. 494–502. 21 indexed citations
5.
Colella, Pasqualina, Helena Costa Verdera, Francesco Puzzo, et al.. (2018). AAV Gene Transfer with Tandem Promoter Design Prevents Anti-transgene Immunity and Provides Persistent Efficacy in Neonate Pompe Mice. Molecular Therapy — Methods & Clinical Development. 12. 85–101. 54 indexed citations
6.
Poletti, Valentina, Sabine Charrier, Guillaume Corre, et al.. (2018). Preclinical Development of a Lentiviral Vector for Gene Therapy of X-Linked Severe Combined Immunodeficiency. Molecular Therapy — Methods & Clinical Development. 9. 257–269. 33 indexed citations
7.
Ronzitti, Giuseppe, Giulia Bortolussi, Remco van Dijk, et al.. (2016). A translationally optimized AAV-UGT1A1 vector drives safe and long-lasting correction of Crigler-Najjar syndrome. Molecular Therapy — Methods & Clinical Development. 3. 16049–16049. 48 indexed citations
8.
Armbruster, Nicole, Annalisa Lattanzi, Laetitia van Wittenberghe, et al.. (2016). Efficacy and biodistribution analysis of intracerebroventricular administration of an optimized scAAV9-SMN1 vector in a mouse model of spinal muscular atrophy. Molecular Therapy — Methods & Clinical Development. 3. 16060–16060. 39 indexed citations
9.
Poletti, Valentina, Sabine Charrier, Samia Martin, et al.. (2016). Preclinical Development of Gene Therapy for X-Linked Severe Combined Immunodeficiency (SCID-X1). Blood. 128(22). 4705–4705. 1 indexed citations
10.
Georger, Christophe, Béatrice Marolleau, Laurence Jeanson-Leh, et al.. (2015). Short-lived recombinant adeno-associated virus transgene expression in dystrophic muscle is associated with oxidative damage to transgene mRNA. Molecular Therapy — Methods & Clinical Development. 2. 15010–15010. 14 indexed citations
12.
Guiner, Caroline Le, Laurent Servais, Bernard Gjata, et al.. (2015). Adeno-associated virus vector (AAV) microdystrophin gene therapy prolongs survival and restores muscle function in the canine model of Duchenne muscular dystrophy (DMD). Neuromuscular Disorders. 25. S315–S315. 2 indexed citations
13.
Decostre, V., Alban Vignaud, Béatrice Matot, et al.. (2013). Longitudinal in vivo muscle function analysis of the DMSXL mouse model of myotonic dystrophy type 1. Neuromuscular Disorders. 23(12). 1016–1025. 6 indexed citations
14.
Bouazza, Belaïd, Gueorgui Kratassiouk, Bernard Gjata, et al.. (2009). Analysis of growth factor expression in affected and unaffected muscles of oculo-pharyngeal muscular dystrophy (OPMD) patients: A pilot study. Neuromuscular Disorders. 19(3). 199–206. 3 indexed citations
15.
Marangoni, Francesco, Marita Bosticardo, Sabine Charrier, et al.. (2009). Evidence for Long-term Efficacy and Safety of Gene Therapy for Wiskott–Aldrich Syndrome in Preclinical Models. Molecular Therapy. 17(6). 1073–1082. 64 indexed citations
16.
Israeli, David, Bernard Gjata, Rachid Benchaouir, et al.. (2007). Expression of mdr1 is required for efficient long term regeneration of dystrophic muscle. Experimental Cell Research. 313(11). 2438–2450. 3 indexed citations
17.
Sarukhan, Adélaïda, et al.. (2001). Successful Interference with Cellular Immune Responses to Immunogenic Proteins Encoded by Recombinant Viral Vectors. Journal of Virology. 75(1). 269–277. 102 indexed citations
18.
Barrat, F., et al.. (1997). Sex and parity modulate cytokine production during murine ageing. Clinical & Experimental Immunology. 109(3). 562–568. 50 indexed citations
20.
Gjata, Bernard, et al.. (1994). Adjuvant activity of polar glycopeptidolipids of Mycobacterium chelonae (pGPL-Mc) on the immunogenic and protective effects of an inactivated influenza vaccine.. PubMed. 317(3). 257–63. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026